Debt - Narrative (Details) $ in Millions	3 Months Ended
	Mar. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Mar. 31, 2021	Nov. 30, 2019 USD ($)
Debt Instrument [Line Items]
Letters Of Credit Outstanding Amount	$ 4.0
Deferred Finance Costs Noncurrent Gross	23.7
Line of Credit Facility, Remaining Borrowing Capacity	$ 300.0
Line of Credit Facility, Covenant Compliance	As of March 31, 2022 and December 31, 2021, the Company was in compliance with all of the Credit Facility covenants
Line of Credit Facility, Covenant Terms	The Company’s initial consolidated net debt to consolidated adjusted EBITDA ratio could not exceed 4.25 to 1, with step downs in the permitted ratio over the term of the Credit Facility. As of March 31, 2021, the consolidated net debt to adjusted EBITDA may not exceed 3.75 to 1. The Company’s consolidated adjusted EBITDA to interest expense ratio cannot be less than 3.0 to 1 over the term of the agreement. The Credit Facility also prohibits the payment of cash dividends if the Company is in default or if the amount of the dividend paid annually exceeds the greater of $50.0 million and 20% of consolidated adjusted EBITDA unless the ratio of consolidated net debt to consolidated adjusted EBITDA is less than 2.0 to 1, in which case there is no such limitation on amount.
Interest Rate Swap [Member]
Debt Instrument [Line Items]
Derivative Liability Notional Amount				$ 170.0
Credit facility [Member]
Debt Instrument [Line Items]
Percentage of term loan principal amortization year one and two	5.00%
Percentage of term loan principal amortization year three	7.50%
Percentage of term loan principal amortization year four and five	10.00%
Percentage of term loan borrowings				20.00%
Derivative Liability Notional Amount				$ 170.0
Derivative Fixed Interest Rate	3.10%			3.10%
Derivative, Basis Spread on Variable Rate				1.64%
Debt Instrument, Basis Spread on Variable Rate	1.60%
Payments of long-term debt	$ 14.1
Initial consolidated net debt to consolidated EBITDA ratio	4.25
Net debt to consolidated adjusted EBITDA ratio	2.0
Consolidated adjusted EBITDA to interest expense ratio	3.0
Maximum annual cash dividends restriction based on covenants	$ 50.0
Percentage of cash dividends of consolidated adjusted EBITDA	20.00%
Debt, Weighted Average Interest Rate	1.70%
Debt Instrument, Maturity Date	Aug. 01, 2024
Long Term Debt Term	5 years
Credit facility [Member] | Maximum [Member]
Debt Instrument [Line Items]
Net debt to consolidated adjusted EBITDA ratio			3.75
U.S. Term Loan [Member]
Debt Instrument [Line Items]
Debt Issuance Costs, Current, Net	$ 7.2	$ 8.0
Deferred Finance Costs Noncurrent Gross	15.5
Line of Credit Facility, Current Borrowing Capacity	600.0
EURO Term Loan [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Current Borrowing Capacity	150.0
The Revolver [Member]
Debt Instrument [Line Items]
Debt Instrument, Unused Borrowing Capacity, Amount	142.0
Deferred Finance Costs Noncurrent Gross	8.3
Line of Credit Facility, Current Borrowing Capacity	$ 400.0
The Revolver [Member] | Maximum [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Commitment Fee Percentage	0.30%
The Revolver [Member] | Minimum [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Commitment Fee Percentage	0.20%
Industrial Development Bond Due 2028 [Member]
Debt Instrument [Line Items]
Debt Instrument Maturity Date Description	2028
Industrial Development Revenue Bond	$ 10.0	10.0
Bank lines of credit and other debt obligations [Member]
Debt Instrument [Line Items]
Letters Of Credit Outstanding Amount	6.0
Debt Issuance Costs, Current, Net	3.9	$ 4.3
Line of Credit Facility, Remaining Borrowing Capacity	$ 30.0